NCC-MFS2-C1

$600$1,500

Description

Cell line name NCC-MFS2-C1
Accession CVCL_A2EI
Resource Identification Initiative To cite this cell line use: NCC-MFS2-C1 (RRID:CVCL_A2EI)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: 13 hours (PubMed=32870449).
Omics: SNP array analysis.
Derived from site: In situ; Thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
Disease Myxofibrosarcoma (NCIt: C6496)
Myxofibrosarcoma (ORDO: Orphanet_79105)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 71Y
Category Cancer cell line
STR profile

Source(s): PubMed=32870449

Markers:

Amelogenin X,Y
CSF1PO 12
D5S818 11,12
D7S820 9,12
D13S317 9,11
D16S539 9,12
D21S11 30
TH01 6
TPOX 11,12
vWA 14,17

Publications
PubMed=32870449; DOI=10.1007/s13577-020-00420-z
Noguchi R., Yoshimatsu Y., Ono T., Sei A., Hirabayashi K., Ozawa I., Kikuta K., Kondo T.
Establishment and characterization of NCC-MFS2-C1: a novel patient-derived cancer cell line of myxofibrosarcoma.
Hum. Cell 34:246-253(2021)

Cross-references
Encyclopedic resources Wikidata; Q105510292

Additional information

ユーザー種別

Academia/non-profit organization, For-profit organization

Reviews

There are no reviews yet.

Be the first to review “NCC-MFS2-C1”

Your email address will not be published. Required fields are marked *

CAPTCHA